Z-1493-2021 Class II Ongoing
FDA device recall Z-1493-2021 was initiated by Cytocell Ltd. on Mar 19, 2021 and is designated Class II. Reason for recall: Users may observe additional locus specific signals at 9q34. The device pack insert indicates the probe has no known cross-reactivity to 9q34. The recall status is ongoing. Affected quantity: 89 probes.
Recall details
- Product Type
- Devices
- Report Date
- May 5, 2021
- Initiation Date
- Mar 19, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 89 probes
Product description
Chromosome X Alpha-Satellite in FITC Spectrum - Product Usage: Analyte Specific Reagents. Model: MPA3481
Reason for recall
Users may observe additional locus specific signals at 9q34. The device pack insert indicates the probe has no known cross-reactivity to 9q34.
Distribution pattern
US Nationwide distribution in the states of TX, OH, NY, IL, CT, AL, IA, MO.
Code information
Lot: RD20/253/16, RD21/043/01, RD21/043/02
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1493-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026